Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for GRFS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
March 31, 2026 36.47%
December 31, 2025 34.66%
September 30, 2025 39.33%
June 30, 2025 37.81%
March 31, 2025 38.90%
December 31, 2024 38.79%
September 30, 2024 40.53%
June 30, 2024 34.15%
March 31, 2024 38.80%
December 31, 2023 39.09%
September 30, 2023 39.42%
June 30, 2023 34.26%
March 31, 2023 36.37%
March 31, 2021 45.02%
December 31, 2020 45.10%
September 30, 2020 47.71%
June 30, 2020 32.32%
March 31, 2020 45.71%
December 31, 2019 44.72%
September 30, 2019 46.15%
June 30, 2019 47.21%
March 31, 2019 45.65%
December 31, 2018 42.36%
September 30, 2018 45.92%
June 30, 2018 45.35%
Date Value
March 31, 2018 47.78%
December 31, 2017 48.46%
September 30, 2017 50.23%
June 30, 2017 47.95%
March 31, 2017 51.04%
December 31, 2016 44.04%
September 30, 2016 44.91%
June 30, 2016 45.26%
March 31, 2016 47.49%
December 31, 2015 47.21%
September 30, 2015 47.70%
June 30, 2015 45.98%
March 31, 2015 47.44%
December 31, 2014 48.28%
September 30, 2014 51.61%
June 30, 2014 46.99%
March 31, 2014 52.72%
December 31, 2013 48.62%
September 30, 2013 51.09%
June 30, 2013 51.72%
March 31, 2013 51.19%
December 31, 2012 49.85%
September 30, 2012 51.94%
June 30, 2012 51.51%
March 31, 2012 49.68%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Amarin Corp. Plc 37.96%
Cellectis SA 21.50%
Autolus Therapeutics Plc 6.29%
Akari Therapeutics Plc --
Evaxion AS --